Unknown

Dataset Information

Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.


ABSTRACT:

Background

Methods for screening agents earlier in development and strategies for conducting smaller randomized controlled trials (RCTs) are needed.

Methods

We retrospectively applied a tumor growth model to estimate the rates of growth of pancreatic cancer using radiographic tumor measurements or serum CA 19-9 values from 3033 patients with stages III-IV PDAC who were enrolled in 8 clinical trials or were included in 2 large real-world data sets.

Results

g correlated inversely with OS and was consistently lower in the experimental arms than in the control arms of RCTs. At the individual patient level, g was significantly faster for lesions metastatic to the liver relative to those localized to the pancreas. Regardless of regimen, g increased toward the end of therapy

SUBMITTER: Yeh C 

PROVIDER: S-EPMC9907043 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature